ING1 Antibodies

Santa Cruz Biotechnology provides a broad selection of ING1 monoclonal antibodies for research focused on understanding inhibitor of growth family member 1 (ING1) protein. ING1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ING1 functions as a key regulator of cell growth and apoptosis, demonstrating significant tumor suppression capabilities. Through chromatin remodeling and transcriptional regulation, ING1 influences various cellular processes essential for maintaining healthy cell function. Research has shown that ING1 expression levels often correlate with cancer progression and treatment outcomes. Understanding ING1's role in cellular stress response mechanisms continues to reveal new possibilities for targeted therapies. Investigating ING1's interaction with other proteins provides valuable insights into cancer development pathways. Current studies highlight ING1's importance in DNA repair and cell cycle regulation. Santa Cruz Biotechnology monoclonal antibodies for ING1 enable researchers worldwide to advance cancer biology understanding and develop innovative therapeutic approaches.